|
HS Code |
438048 |
| Product Name | 3-Bromo-4-Iodopyridine |
| Chemical Formula | C5H3BrIN |
| Cas Number | 885276-00-4 |
| Appearance | White to off-white solid |
| Melting Point | 82-85°C |
| Purity | Typically ≥98% |
| Solubility | Soluble in organic solvents like DMSO, DMF |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Smiles | C1=CN=CC(=C1Br)I |
| Inchi | InChI=1S/C5H3BrIN/c6-4-1-2-8-3-5(4)7 |
| Synonyms | 4-Iodo-3-bromopyridine |
| Hazard Statements | May cause irritation to skin, eyes, and respiratory tract |
As an accredited 3-Bromo-4-Iodopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-4-Iodopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the busy world of chemical development, some building blocks never seem to leave the bench or the conversation. 3-Bromo-4-Iodopyridine earns its spot among them. Lab notebooks from academia to commercial process teams show countless margin notes beside sketches of its structure, as teams keep running into targets that demand a clever halogenated pyridine scaffold. Over the years, its unique mix of reactivity, flexibility, and selectivity helped me and plenty of other chemists solve those problems you can’t just tackle with plain old pyridine. Some molecules carry potential that’s bigger than their size, and this one belongs in that league.
Before rushing to use any new reagent, I learned to check its details, because chemistry has a way of rewarding careful eyes. 3-Bromo-4-Iodopyridine draws attention with two heavy atoms sitting at the 3- and 4-positions on the pyridine ring. This structural quirk makes it quite different from more basic halopyridines you might spot in a catalogue. You get specificity in cross-coupling routes that is hard to match elsewhere at this price point. The compound usually appears as a light to off-white solid, and each batch must hit tight purity standards since modern methods can pick up even low-level contaminants and turn them into headaches downstream.
On paper, the dual halogen setup stands out for more than its odd numbering: the electron-rich and -deficient character runs along the ring in a way that changes how each site reacts with partners. In Suzuki, Buchwald–Hartwig, or Stille couplings, you see selectivity roll out depending on the catalyst you pick and the order you run each reaction. This isn’t just textbook talk. A few years back, I needed to swap one halogen, slip in an alkyl side chain, and keep the rest of the molecule whole. Products like 3-Bromo-4-Iodopyridine allowed me to control each step in a logical, reproducible way, where ordinary dihalopyridines just threw up a mess of byproducts or led to low yields.
In practice, using 3-Bromo-4-Iodopyridine opens doors across medicinal chemistry and materials science. Libraries of candidate drugs rely on diversity in their pyridine cores, and this molecule lends flexibility to the design process. Compared to other dihalopyridines, it handles cross-coupling with a much wider scope. For example, it plays well with both electron-rich and electron-poor partners, making it far easier to stick different groups on either side without blowing up the other end of the molecule.
Medicinal chemists have long learned to appreciate what this means for synthesizing kinase inhibitors, anti-infective cores, or diagnostic tools. The iodine leaves first and more smoothly under most palladium-catalyzed reactions, allowing selective functionalization. Bromine holds up for a second round, ready for another coupling or a nucleophilic swap. Each time I helped push a series of analogs through late-stage diversification, I saw how having both halogens, and controlling their order, created dozens of analogs quickly—sometimes making the difference between a compound that simply looked good on paper and one that performed well in the assay.
On the process side, the story spreads out. Custom materials often need scaffolds that handle tough reaction conditions without falling apart. Here again, the dual-halogen nature allows several generations of substitution and further elaboration that single-halogenated pyridines can’t offer without extra steps. A kilo lab I worked with once struggled to make a substituted pyridine for OLED work—the cost and time savings with 3-Bromo-4-Iodopyridine beat their expectations, because they could plan a two-step telescoped sequence, cutting out an entire purification. That’s real improvement, not just a talking point.
Specs mean everything in practical chemistry. Nobody wants to troubleshoot downstream failures caused by unspecified impurities or mixed halogen ratios. In my own experience, I never just assume the material on a label matches what goes into my flask. Decent suppliers screen each batch with NMR and LC-MS before release; purity at or above 98 percent keeps side reactions low enough to be routine in pharmaceutical development work. Water content, if not controlled, can creep up and delay reactions or outright ruin strong bases, so proper handling and packaging matter a lot more with labile halopyridines than with bench-stable aryl bromides. I always store these in airtight containers, and if a bottle has sat too long, a quick check by TLC or NMR never hurts.
Some researchers need metal residue limits kept very tight, especially if they’re developing regulatory filings or making starting materials for scale-up. Most production processes can’t absorb a surprise from an overactive byproduct or a hidden trace of the wrong halogen. Reputable sources will provide certificates of analysis without any arm-twisting, building trust that you only earn by running through the hard lessons a few times.
You don’t have to look far to find other halopyridine choices; take 2-Bromo-5-Iodopyridine or 3,5-Dibromopyridine as examples. Each brings its own benefits and tradeoffs, so reaching for 3-Bromo-4-Iodopyridine calls for a clear reason. My experience says that selectivity and step economy tip the decision. The 3- and 4-position halogens, sitting right next to each other, let synthetic schemes build out complex molecules with minimal protecting group games or tedious functional group juggling.
Consider cases where you want to stitch together two different aromatic or heterocyclic motifs. A standard diiodopyridine can open both ends at once, which is great for shotgun-style library work, but you risk cross-reactivity and struggling to control the domino effect of multiple coupling steps. On the flip side, using a simple monohalogenated pyridine usually runs up against the wall of making only one kind of modification—limiting the ways you can tweak your core for better biological or physical properties.
3-Bromo-4-Iodopyridine lands right in the sweet spot. The two halogens react at different speeds, so you build up your target in a controlled way. I’ve seen projects go from a slow one-analogue-per-week pace to turning out entire series in days, just because the functional handles made things modular. The value here isn’t only for research teams; process chemists building out pilot-scale batches appreciate the reduced need for protecting groups and purification steps. Every time you simplify the route, you cut costs, reduce errors, and build in greater scalability.
Working in research settings shaped my appreciation for how little changes in a molecule’s structure lead to huge jumps in synthetic power. Years ago, as a grad student in a small group, our main project revolved around generating focused libraries for structure-activity studies. I remember how stuck we felt with basic halopyridines—selectivity always lagged, and yields shot down when trying to perform two couplings in sequence. We spent weeks cleaning up messy mixtures and hoping for lucky chromatographic splits. Our work changed quickly the day someone suggested 3-Bromo-4-Iodopyridine. One by one, the problems left the table: functionalizing without over-reacting, scaling up reactions, getting better purity for analysis.
The compound connected the dots between clever synthesis and practical output. That experience, repeated later in the industry world, brought home a lesson that sticks: sometimes creative chemistry happens when you let go of brute force routes and let the molecule’s structure do the work. Good design means picking reagents that do more than just fill a checkbox in a scheme—they let your ideas flow with fewer detours and less frustration.
Interest in 3-Bromo-4-Iodopyridine spans more than small-molecule drug work. In material science, especially where tuning of electronics or solubility matters, the ability to swap, add, or delete groups with precision along the pyridine ring transforms development cycles. New dyes, polymers, and photoactive systems often start from just such halogenated intermediates. A well-placed bromine and iodine offer easy entry for all sorts of novel partners—a shortcut others notice only after struggling with precursor limitations of less appropriately substituted pyridines.
Still, challenges exist. Supply chain disruptions, growing demand for high-purity materials, and pressure on halogenated intermediates make sourcing trickier now than 10 years ago. Strict regulations around halogenated waste and environmental hazard management raise costs and slow timelines. My take is that tight relationships with reliable suppliers, combined with ongoing internal analytical testing, help ease these bumps. You learn that making chemistry work at scale is more than picking a flashy reagent—it means planning for every step from bottle to bench to waste drum.
Over the years, a key question has come up more often: what does responsible chemistry look like with materials like 3-Bromo-4-Iodopyridine? Making, using, and disposing of halogenated compounds calls for careful handling. Modern synthetic labs, from academia to pharma, now build waste minimization and recycling strategies into their operations. Safe disposal procedures, solvent recovery, and investment in flow chemistry help keep hazards low. Whenever I teach or mentor, I stress that handling materials like these starts with respect for both their power in synthesis and their impact outside the lab.
Forward-thinking companies have begun offering improved production routes for 3-Bromo-4-Iodopyridine, swapping out outdated, hazardous methods for greener alternatives that cut down on unnecessary byproducts. These efforts also focus on making purification more energy-efficient, reducing solvent waste, and sometimes even allowing for recycling of spent reactants. Teams who stay proactive—screening new methods, engaging with environmental chemists, and talking openly with suppliers—set themselves up for long-term success, not just short-term wins.
My own routines developed from hard experience. I always start new reactions with small-scale trials, because even a familiar molecule like this one can surprise you with a stubborn impurity or an unusual side reaction on a new substrate. I keep meticulous records of equivalents and reaction times, since halogenated intermediates can reveal small variances only after you run a handful of test batches. Ensuring thorough mixing, steady addition of coupling agents, and careful drying of solvents rewards patience with higher yields and fewer failures.
Every chemist has their favorite catalyst and ligand set. With 3-Bromo-4-Iodopyridine, selection can shift depending on whether the planned bond formation is on the iodine or the bromine end. For example, working up a Suzuki coupling, palladium catalysts paired with phosphine ligands give sharp, clean conversions on the iodine, while bromine substitutions sometimes benefit from extra electron-rich ligands or a little extra heating. I’ve seen stubborn partners react just fine after tweaking stoichiometry or swapping bases—details that only consistent use brings out. Patience pays dividends.
It’s one thing to rely on reagent specs, another to truly know what you’re working with. I’ve contacted suppliers more than once for extra data—NMR, HPLC, or elemental analysis—before committing to a multi-thousand dollar order. The reassurance pays off, especially for projects that run tight deadlines or face regulatory scrutiny. Having worked with both good and bad suppliers, I know the difference shows up not just in the certificate of analysis, but in how often you find yourself needing to debug a protocol or clean up messy reaction profiles. Quality, in this case, means peace of mind more than anything else.
Reproducibility depends on more than the bottle you open. I invest a bit of time in pre-reaction analysis, checking melting point and chromatograms, spotting trouble before it grows. For anyone scaling up reactions, batch-to-batch consistency holds even greater value; a little extra work up front buys longer, smoother campaigns and higher throughputs.
Chemical tools like 3-Bromo-4-Iodopyridine keep evolving. As cross-coupling chemistry shifts, demand rises for reagents that play well with less toxic metals, aqueous phases, or lower-cost catalyst systems. Some labs have started to document routes where nickel, copper, and even iron catalysis offer cheaper and more sustainable alternatives to palladium. The dual-halogen setup holds promise for those fields, since orthogonal reactivity unlocks synthetic space without forcing complicated workarounds.
I’ve heard from teams developing continuous flow platforms who look for robust, stable intermediates—they want to move away from heavy batch purification and make process development faster, cheaper, and greener. 3-Bromo-4-Iodopyridine stacks up well in these settings, offering predictable, programmable transformations that streamline route scouting. As new demands shape the pharmaceutical and materials fields, the right building blocks will continue to matter, and this one should stay in the mainstream of creative synthetic planning.
From delivering reliable supply chains to reducing environmental footprint, every stakeholder has a role to play. Based on years in both research and process labs, I encourage researchers to open a direct conversation with suppliers—clarifying purity, moisture limits, and batch consistency before large projects kick off. Getting technical support up front saves days of frustration later and sets up a smoother path from bench to published results or clinical candidates.
Teams juggling dual demands of rapid R&D and tight regulatory oversight can build in extra redundancy, keeping backup sources in the pipeline and splitting orders between trusted vendors. Analytical teams should keep verifying incoming lots, flagging deviations quickly, and feeding back that info into their supply approval process. Making these habits routine not only avoids missed project milestones, but also builds a culture where reliability trumps short-term convenience.
For environmental and safety matters, consider investing in solvent recovery units, closed-loop waste handling, and robust training for handling halogenated reagents. Many organizations spread this knowledge through regular in-house workshops or safety walkthroughs—practical habits that save both money and reputations.
Looking back on the growing reliance on advance building blocks like 3-Bromo-4-Iodopyridine, I see not just a tool, but a learning opportunity for any chemist hoping to break new ground in synthesis. Experience teaches that smart choices at the molecular level ripple out into big impacts—richer libraries, better process routes, faster discoveries, and more responsible chemistry overall. Subtle differences in structure, like those found between various halopyridines, have the power to reshape what’s possible in the lab. For me and many colleagues, 3-Bromo-4-Iodopyridine isn’t just another bottle on the shelf; it represents a quiet revolution in problem-solving, flexibility, and scientific growth.